{"id":173901,"url":"https://lda.senate.gov/api/v1/clients/173901/?format=json","client_id":583,"name":"AEGERION PHARMACEUTICALS A NOVELION THERAPEUTICS COMPANY","general_description":"develop new standards of care for individuals living with rare diseases,pharmaceuticals","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-02-01","registrant":{"id":88278,"url":"https://lda.senate.gov/api/v1/registrants/88278/?format=json","house_registrant_id":36652,"name":"UPSTREAM CONSULTING, INC.","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-01-30T14:34:13.771970-05:00"}}